Respiratory virus infections in the immunocompromised host

Paediatric Respiratory Reviews

Volumn 4, Issue 3, 2003, Pages 193-204

  Soldatou, Alexandra ^a   Davies, E Graham ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Antiviral therapy; Cytomegalovirus; Immunodeficiency; Immunoglobulin; Immunotherapy; Respiratory virus; Transplantation

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AMANTADINE; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; BETA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; CIDOFOVIR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; PLECONARIL; PREDNISOLONE; RIBAVIRIN; SIALIDASE INHIBITOR; TACROLIMUS; UNINDEXED DRUG; VALACICLOVIR; VIRUS VACCINE; ZANAMIVIR;

ADENOVIRUS; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CHILD; CHILD CARE; COMPUTER ASSISTED TOMOGRAPHY; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HELPER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC ANEMIA; HERPES VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOCYTE TRANSFER; MEASLES; MEASLES VIRUS; METAPNEUMOVIRUS; NATURAL KILLER CELL; NOSE SMEAR; ORGAN TRANSPLANTATION; ORTHOMYXOVIRUS; PARAINFLUENZA VIRUS; PARAMYXOVIRUS; PHAGOCYTE; PICORNAVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; RECIPIENT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RISK MANAGEMENT; THORAX RADIOGRAPHY; THROAT CULTURE; TREATMENT OUTCOME; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REACTIVATION; WHOLE BODY RADIATION;

EID: 0043026798     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0542(03)00061-7     Document Type: Review

References (62)

1. Fleisher T, Bleesing J. Immune function. Pediatr Clin N Am 2000; 47: 1197-1209.
2. Couch RB, Englund JA, Whimbley E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997; 102: 2-9.
3. Young DF, Randall RE, Hoyle JA, Souberbielle BE. Clearance of persistent paramyxovirus infection is mediated by cellular immune responses but not by serum neutralising antibody. J Virol 1990; 64: 5403-5411.
4. Van den Broek MF, Muller U, Huang S et al. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev 1995; 148: 5-18.
5. Jawahar S, Moody C, Chan M, Finberg R, Geha R, Chatila T. Natural killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II). Clin Exp Immunol 1996; 103: 408-413.
6. Uzel G, Premkumar A, Malech HL, Holland SM. Respiratory syncytial virus infection in patients with phagocyte defects. Pediatrics 2000; 106: 835-837.
7. Woroniecka M, Ballow M. Office evaluation of children with recurrent infection. Pediatr Clin N Am 2000; 47: 1211-1224.
8. Siegal FP, Dikman SH, Arayata RB et al. Fatal disseminated adenovirus II pneumonia in an agammaglobulinemic patient. Am J Med 1981; 71: 1062-1067.
9. Kainulainen L, Nikoskelainen J, Vuorinen T, Tevola K, Liippo K, Ruuskanen O. Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med 1999; 159: 1199-1204.
10. Department of Health. A Guide to Immunisation: The Green Book. HMSO, London, 1996.
11. Mukwaya G. Immunosuppressive effects and infections associated with corticosteroid therapy. Ped Inf Dis J 1988; 7: 499-504.
12. Nichols WG, Corey L, Gooley T et al. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001; 98: 573-578.
13. Madhi SA, Schoub B, Simmank K, Blackburn N, Klugman KP. Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-I. J Pediatr 2000; 137: 78-84.
14. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Pediatric AIDS. Measles immunization in HIV-infected children. Pediatrics 1999; 103: 1057-1060.
15. Sharland M, Gibb DM, Tudor-Williams G. Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom. Arch Dis Child 2002; 87: 178-180.
16. Ljungman P, Ward KN, Crooks BN et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Bone Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479-484.
17. Crooks BN, Taylor CE, Tuner AJ et al. Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit. Bone Marrow Transplant 2000; 26: 1097-1102.
18. Wendt CH. Community respiratory viruses: organ transplant recipients. Am J Med 1997; 102: 31-36.
19. Billings JL, Hertz MI, Wendt CH. Community respiratory viruses following lung transplantation. Transplant Infect 2001; 3: 138-152.
20. Ison M, Hayden F. Viral infections in immunocompromised patients: what's new with respiratory viruses? Curr Op Infect Dis 2002; 15: 355-367.
21. Palmer SM Jr, Henshaw NNG, Howell DN et al. Community respiratory viral infections in adult lung transplant recipients. Chest 1998; 113: 944-950.
22. Vilchez RA, McCurry K, Dauber J et al. The epidemiology of parainfluenza infection in lung transplant recipients. Clin Infect Dis 2001; 33: 2004-2008.
23. Cane PA, van den Hoogen BG, Chakrabarti S et al. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant 2003; 31: 309-310.
24. Pelletier G, Dery P, Abed Y et al. Respiratory tract re-infections by the new human Metapneumovirus in an immunocompromised child. Emerg Infect Dis 2002; 8: 976-978.
25. Gray MM, Hann IM, Glass S, Eden OB, Jones PM, Stevens RF. Mortality and morbidity caused by measles in children with malignant disease attending four major treatment centres: a retrospective review. BMJ 1987; 295: 19-22.
26. Goon P, Cohen B, Jin L, Watkins R, Tudor-Williams G. MMR vaccine in HN-infected children - potential hazards. Vaccine 2001; 19: 3816-3819.
27. Kappagoda C, Isaacs D, Mellis C, Peat J, De Silva L, O'Connell A. Critical influenza virus infection. J Paediatr Child Health 2000; 36: 318-321.
28. Aplasch AM, Green M, Ledesma-Medina J et al. Parainfluenza and Influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995; 20: 394-399.
29. Madhi SA, Ramasamy N, Bessellar TG, Saloojee H, Klugman KP. Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type I infection. Pediatr Infect Dis J 2002; 21: 291-297.
30. Gonzalez Y, Martino R, Badell I et al. Pulmonary enterovirus infections in stem cell transplant recipients. Bone Marrow Transplant 1999; 23: 511-513.
31. Kaiser L, Hayden FG. Rhinovirus pneumonia: a clinical entity? Clin Infect Dis 1999; 29: 533-535.
32. Carrigan D. Adenovirus infections in immunocompromised patients. Am J Med 1997; 102: 71-74.
33. Olszewska W, Zambon M, Openshaw PJM. Development of vaccines against common colds. Br Med Bull 2002; 62: 99-111.
34. Flomenberg P, Babbitt J, Drobyski WR et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994; 169: 775-781.
35. Hale GA, Heslop HE, Krance RA et al. Adenovirus infection after pediatric BMT. Bone Marrow Transplant 1999; 23: 277-282.
36. Michaels MG, Green M, Wald ER, Starzl TE. Adenovirus infection in paediatric liver transplant recipients. J Inf Dis 1992; 165: 170-174.
37. Ohori NP, Michaels Mgjaffe R et al. Adenovirus pneumonia in lung transplant recipients, Human Pathol 1995; 26: 1073-1079.
38. Ljungman P. Prevention and treatment of viral infections in stem cell transplant recipients. Br J Haem 2002; 118: 44-57.
39. Isada CM, Yen-Leiberman B, Lurain NS et al. Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection. Transpl Infect Dis 2002; 4: 189-194.
40. Cone RW. Human herpesvirus 6 as a possible cause of pneumonia. Semin Respir Infect 1995; 10: 254-258.
41. Lee LM, Henderson DK. Emerging viral infections. Curr Opin Infect Dis 2001; 14: 467-480.
42. Labenne M, Hubert P, Gaillard JL et al. Diagnosis of pulmonary infections in critically ill immunocompromised children. Pediatr Pulmonol 1997; 16(Suppl.): 59-60.
43. Copley SJ. Application of computed tomography in childhood respiratory infections. Br Med Bull 2002; 61: 263-279.
44. Liolios L, Jenney A, Spelman D et al. Comparison of a multiplex reverse transcription - PCR-enzyme hybridisation assay with conventional viral culture and immunofluorescent techniques for the detection of seven viral respiratory pathogens. J Clin Microbiol 2001; 39: 2779-2783.
45. Griffiths PD, Cope AV, Hassan-Walker AF, Emery VC. Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation. Transpl Infect Dis 1999; 1: 179-186.
46. Garcia R, Raad I, Abi-Said D et al. Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infect Control Hosp Epidemiol 1997; 18: 412-416.
47. Lewinsohn DM, Bowden RA, Mattson D, Crawford SW. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrob Agents Chemother 1996; 40: 2555-2557.
48. Englund JA, Champlin RE, Wyde PR et al. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 1998; 26: 1418-1424.
49. Johny AA, Clark A, Price N et al. The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 29: 113-115.
50. Gubareva LV, Mastrovich MN, Brenner MK et al. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis 1998; 178: 1257-1262.
51. Rotbart HA, Webster DA and the Pleconaril Treatment Registry Group. Treatment of potentially life-threatening enterovirus infections with Pleconaril. Clin Infect Dis 2001; 32: 228-235.
52. Bordigoni P, Carret AS, Venard V et al. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2001; 32: 1290-1297.
53. Hoffman JA, Shah AJ, Ross LA, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 388-394.
54. Meszner Z, Nyerges G, Bell AR et al. Oral Acyclovir to prevent dissemination of varicella in immunocompromised children. J Infect 1993; 26: 9-15.
55. Ljungman P, De La Camara R, Milpied N et al. A randomised study of valacyclovir as prophylaxis against CMV reactivation in allogeneic bone marrow transplant recipients. Blood 2002; 99: 3050-3056.
56. Ljungman P, Deliliers GL, Platzbecker U et al. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood 2001; 97: 388-392.
57. Wang FZ, Dahl H, Linde A et al. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996; 88: 3615-3620.
58. Boeckh M, Berney MM, Bowden RA et al. Phase I evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis 2001; 184: 350-354.
59. Hromas R, Cometta K, Srour E et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 1994; 84: 1689-1690.
60. Andre-Schmutz I, Le Deist F, Hacein-Bey-Abina S et al. Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study. Lancet 2002; 360: 130-161.
61. Gahn B, Hunt G, Rooney CM, Heslop HE. Immunotherapy to reconstitute immunity to DNA viruses. Semin Hematol 2002; 39: 41-47.
62. Haque T, Wilkie GM, Taylor C et al. Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet 2002; 360: 436-442.